CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 80 filers reported holding CELLECTIS S A in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $64,000 | +433.3% | 3,600 | +367.5% | 0.00% | +300.0% |
| Q2 2019 | $12,000 | -89.4% | 770 | -80.8% | 0.00% | -85.7% |
| Q3 2018 | $113,000 | +10.8% | 4,000 | +11.1% | 0.01% | +16.7% |
| Q2 2018 | $102,000 | +29.1% | 3,600 | +44.0% | 0.01% | 0.0% |
| Q1 2018 | $79,000 | +12.9% | 2,500 | +4.2% | 0.01% | 0.0% |
| Q4 2017 | $70,000 | +22.8% | 2,400 | +20.0% | 0.01% | +20.0% |
| Q3 2017 | $57,000 | -55.1% | 2,000 | -59.2% | 0.01% | -58.3% |
| Q2 2017 | $127,000 | +32.3% | 4,900 | +22.5% | 0.01% | +33.3% |
| Q1 2017 | $96,000 | +12.9% | 4,000 | -20.0% | 0.01% | -10.0% |
| Q4 2016 | $85,000 | +77.1% | 5,000 | +150.0% | 0.01% | +100.0% |
| Q3 2016 | $48,000 | +54.8% | 2,000 | +100.0% | 0.01% | 0.0% |
| Q4 2015 | $31,000 | +19.2% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $26,000 | -67.1% | 1,000 | -54.5% | 0.00% | -63.6% |
| Q2 2015 | $79,000 | +125.7% | 2,200 | +120.0% | 0.01% | +120.0% |
| Q1 2015 | $35,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |